{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-000562","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2025-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.623747+00:00","generated_at":"2026-05-23T17:13:12.631908+00:00","sec_items":["3.02","8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Renovaro completes acquisition of Biosymetrics, issues 15M shares","bullets":["Consummated merger with Biosymetrics on April 8, 2025; Biosymetrics becomes wholly owned subsidiary.","Issued 15.0 million shares of Renovaro common stock to former Biosymetrics stockholders.","Shares issued in reliance on Section 4(a)(2) exemption based on accredited investor representations.","Transaction was previously announced on February 26, 2025 via Merger Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-000562","json":"https://secwatch.observer/filing/0001731122-25-000562.json","markdown":"https://secwatch.observer/filing/0001731122-25-000562.md","text":"https://secwatch.observer/filing/0001731122-25-000562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000562/0001731122-25-000562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000562/e6512_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T17:13:12.631908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}